Nearly a third of French people change the dose and duration of their treatment without medical advice

2023-06-09 11:25:30 Faced with this misuse, which has significant consequences for health, the drug agency is launching an information campaign. «Medicines are not ordinary products, do not take them lightly“Recalls the National Medicines Safety Agency (ANSM). This Wednesday, the health authority is launching a general public campaign on their proper use, a “major public health … Read more

Have your say: Consultation on Improving Access to Medicines and Other Health Products in Canada

2023-06-05 17:00:00 Current status: In progress Comment period: June 5 to August 4, 2023. Medicines and other health products are essential to improving and maintaining our health. Supply disruptions can cause hardship for people in Canada, as well as their families, and can put a strain on our health care system. In November 2022, Health … Read more

“Uncovering the Signatures of Brain Activity: A Step Towards a New Treatment for Chronic Pain”

2023-05-24 07:15:44 Worldwide, chronic pain is one of the main contributors to disability, while this type of pain does not respond well to current treatments. A new study shows a first step in uncovering the signatures of brain activity that underlie our perception of pain. You will also be interested [EN VIDÉO] Reduce pain with … Read more

“Reviving Forgotten Antibiotics: Fighting Drug-Resistant Superbugs with Nourseothricin”

2023-05-19 07:29:30 Drug-resistant superbugs that cause serious infections pose a public health threat. An antibiotic identified about 80 years ago, then forgotten, has just been reanalyzed by scientists. You may also be interested [EN VIDÉO] Antibiotic resistance of bacteria, a growing threat Antibiotics have the property of killing or limiting the spread of bacteria. Gold,… … Read more

Eli Lilly’s Promising Results in Alzheimer’s Treatment Clinical Trial

2023-05-04 08:48:02 The American pharmaceutical group Eli Lilly has announced that it has obtained very promising results during a large-scale clinical trial. The American pharmaceutical group Eli Lilly said on Wednesday that its new treatment developed against Alzheimer’s had been shown, during a large clinical trial, to slow the progression of the disease, an announcement … Read more

“Sleeping Pill Study Shows Potential to Reduce Alzheimer’s Disease Toxins”

2023-04-21 17:19:26 Accumulation of amyloid beta protein is considered a determining factor in Alzheimer’s disease. As part of a small study, researchers have found a benefit to a sleeping pill: reduce levels of toxic proteins in the central nervous system. You will also be interested [EN VIDÉO] The role of sleep Sylvie Royant-Parola, psychiatrist and … Read more

These researchers made a discovery while trying to twist a molecule

In one study, scientists sought to twist molecules until they break. Their aim was to challenge their understanding of chemical bonds. They were mainly interested in aromatic rings. Because, an aromatic molecule has several uses, particularly in pharmacology and in the materials industry. In fact, she has a reputation for being a particularly stable molecule. … Read more

ANSES again warns against excess vitamin D for infants

The National Agency for Food, Environmental and Occupational Health Safety (ANSES) again warned on Wednesday of the risks of excess vitamin D in infants, after the discovery of three new cases. of overdose. “An excess of vitamin D can have serious consequences on their health and threaten the vital prognosis of toddlers. To limit the … Read more